ID   WEE1_RAT                Reviewed;         646 AA.
AC   Q63802; Q5EAN3;
DT   13-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 172.
DE   RecName: Full=Wee1-like protein kinase;
DE            EC=2.7.10.2 {ECO:0000250|UniProtKB:P30291};
DE   AltName: Full=Wee1A kinase;
GN   Name=Wee1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Furunobu A.;
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78 AND SER-85, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Acts as a negative regulator of entry into mitosis (G2 to M
CC       transition) by protecting the nucleus from cytoplasmically activated
CC       cyclin B1-complexed CDK1 before the onset of mitosis by mediating
CC       phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and
CC       inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase
CC       and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1
CC       occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1
CC       does not occur. Its activity increases during S and G2 phases and
CC       decreases at M phase when it is hyperphosphorylated. A correlated
CC       decrease in protein level occurs at M/G1 phase, probably due to its
CC       degradation. {ECO:0000250|UniProtKB:P30291}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000250|UniProtKB:P30291, ECO:0000255|PROSITE-
CC         ProRule:PRU10027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10597;
CC         Evidence={ECO:0000250|UniProtKB:P30291};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P30291};
CC       Note=Binds 2 magnesium ions per subunit.
CC       {ECO:0000250|UniProtKB:P30291};
CC   -!- ACTIVITY REGULATION: Synthesis is increased during S and G2 phases,
CC       presumably by an increase in transcription; activity is decreased by
CC       phosphorylation during M phase. Protein levels fall in M phase as a
CC       result of decreased synthesis combined with degradation. Activity seems
CC       to be negatively regulated by phosphorylation upon entry into mitosis,
CC       although N-terminal phosphorylation might also regulate the protein
CC       stability via protection from proteolysis or might regulate the
CC       subcellular location (By similarity). {ECO:0000250|UniProtKB:P30291}.
CC   -!- SUBUNIT: Binds to 14-3-3 protein zeta. {ECO:0000250|UniProtKB:P30291}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P30291}.
CC   -!- PTM: Phosphorylated during M and G1 phases. Also autophosphorylated.
CC       Phosphorylation at Ser-642 by BRSK1 and BRSK2 in post-mitotic neurons,
CC       leads to down-regulate WEE1 activity in polarized neurons.
CC       Phosphorylated at Ser-52 and Ser-123 by PLK1 and CDK1, respectively,
CC       generating an signal for degradation that can be recognized by the
CC       SCF(BTRC) complex, leading to its ubiquitination and degradation at the
CC       onset of G2/M phase (By similarity). {ECO:0000250|UniProtKB:P30291}.
CC   -!- PTM: Dephosphorylated at Thr-239 by CTDP1 (By similarity).
CC       Dephosphorylated at Ser-52 and Ser-123 by the serine/threonine-protein
CC       phosphatase 2A preventing its ubiquitin-mediated degradation (By
CC       similarity). {ECO:0000250|UniProtKB:P30291}.
CC   -!- PTM: Ubiquitinated and degraded at the onset of G2/M phase.
CC       {ECO:0000250|UniProtKB:P30291}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. WEE1 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D31838; BAA06624.1; -; mRNA.
DR   EMBL; BC090346; AAH90346.1; -; mRNA.
DR   RefSeq; NP_001012760.1; NM_001012742.1.
DR   AlphaFoldDB; Q63802; -.
DR   SMR; Q63802; -.
DR   STRING; 10116.ENSRNOP00000013362; -.
DR   iPTMnet; Q63802; -.
DR   PhosphoSitePlus; Q63802; -.
DR   jPOST; Q63802; -.
DR   PaxDb; 10116-ENSRNOP00000013362; -.
DR   Ensembl; ENSRNOT00000013362.6; ENSRNOP00000013362.3; ENSRNOG00000010017.7.
DR   Ensembl; ENSRNOT00055043927; ENSRNOP00055035911; ENSRNOG00055025448.
DR   Ensembl; ENSRNOT00060034200; ENSRNOP00060028040; ENSRNOG00060019803.
DR   Ensembl; ENSRNOT00065050766; ENSRNOP00065041728; ENSRNOG00065029399.
DR   GeneID; 308937; -.
DR   KEGG; rno:308937; -.
DR   UCSC; RGD:1307895; rat.
DR   AGR; RGD:1307895; -.
DR   CTD; 7465; -.
DR   RGD; 1307895; Wee1.
DR   eggNOG; KOG0601; Eukaryota.
DR   GeneTree; ENSGT00940000157939; -.
DR   HOGENOM; CLU_000288_25_1_1; -.
DR   InParanoid; Q63802; -.
DR   OMA; DDWVSNK; -.
DR   OrthoDB; 928649at2759; -.
DR   PhylomeDB; Q63802; -.
DR   TreeFam; TF101088; -.
DR   BRENDA; 2.7.11.1; 5301.
DR   Reactome; R-RNO-156711; Polo-like kinase mediated events.
DR   Reactome; R-RNO-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-RNO-69273; Cyclin A/B1/B2 associated events during G2/M transition.
DR   Reactome; R-RNO-69478; G2/M DNA replication checkpoint.
DR   Reactome; R-RNO-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   Reactome; R-RNO-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   PRO; PR:Q63802; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000010017; Expressed in testis and 18 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0030010; P:establishment of cell polarity; ISO:RGD.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISO:RGD.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:InterPro.
DR   GO; GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISO:RGD.
DR   CDD; cd14138; PTKc_Wee1a; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR050339; CC_SR_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017164; Wee1-like_protein_kinase.
DR   PANTHER; PTHR11042; EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE EIF2-ALPHA KINASE -RELATED; 1.
DR   PANTHER; PTHR11042:SF72; WEE1-LIKE PROTEIN KINASE; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037281; Wee1-like_protein_kinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cell division; Kinase; Magnesium; Metal-binding;
KW   Mitosis; Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN           1..646
FT                   /note="Wee1-like protein kinase"
FT                   /id="PRO_0000086812"
FT   DOMAIN          298..568
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          27..175
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        120..136
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        425
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         304..312
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         327
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         341
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   BINDING         430
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   BINDING         462
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   BINDING         464
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         52
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         78
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         123
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         127
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         150
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         165
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P47810"
FT   MOD_RES         187
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         190
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         239
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
FT   MOD_RES         642
FT                   /note="Phosphoserine; by BRSK1 and BRSK2"
FT                   /evidence="ECO:0000250|UniProtKB:P30291"
SQ   SEQUENCE   646 AA;  71496 MW;  740120F51C811DAF CRC64;
     MSFLSRQQPP PTRRAAAACS LRQKLIFSPG SDCEEEEEEE EEGSGHSTGE DSAFQEPDSP
     LPSARSPAEA EAERRRRSPG AEPSSPGELE EDLLLRGGGG GAQAAGGGAE GDSWEEEGFG
     SSSPVKSPTT AYFLGSSFSP VRCGGPGDAS PRGCGVPRAM DDPCSPQPDY PSTPPHKTFR
     KLRLFDTPHT PKSLLSKARV IDSSSVKLRG SSLFMDTEKS GKREFDTRQT PQVNINPFTP
     DPVMLHSSGQ CRGRKRAYFN DSSEDMEASD YEFEDETRPA KRITITESNM KSRYTTEFHE
     LEKIGSGEFG SVFKCVKRLD GCIYAIKRSK KPLAGSVDEQ NALREVYAHA VLGQHPHVVR
     YFSAWAEDDH MLIQNEYCNG GSLADAVSEN YRVMSYFTEA ELKDLLLQVG RGLRYIHSMS
     LVHMDIKPSN IFISRTSIPN AVSEEGDEDD WISNKVMFKI GDLGHVTRIS SPQVEEGDSR
     FLANEVLQEN YSHLPKADIF ALALTVVCAA GAEPLPRNGD QWHEIRQGRL PRIPQVLSQE
     LTELLKVMIH PDPERRPSAM VLVKHSVLLS ASRKSAEQLR IELNAEKFKN SLLQKELKKA
     QMAAKVAAEE RALLTDRMAT RSTTQSNRTS RLIGKKMNRS VSLTIY
//
